Dong Hai-Lin, Li Jia-Qi, Liu Gong-Lu, Yu Hao, Wu Zhi-Ying
Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, and Key Laboratory of Medical Neurobiology of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China.
Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
NPJ Genom Med. 2021 Jan 4;6(1):1. doi: 10.1038/s41525-020-00165-6.
Sorbitol dehydrogenase gene (SORD) has been identified as a novel causative gene of recessive forms of hereditary neuropathy, including Charcot-Marie-Tooth disease type 2 and distal hereditary motor neuropathy (dHMN). Our findings reveal two novel variants (c.404 A > G and c.908 + 1 G > C) and one known variant (c.757delG) within SORD in four Chinese dHMN families. Ex vivo cDNA polymerase chain reaction confirmed that c.908 + 1 G > C variant was associated with impaired splicing of the SORD transcript. In vitro cell functional studies showed that c.404 A > G variant resulted in aggregate formation of SORD and low protein solubility, confirming the pathogenicity of SORD variants. We have provided more evidence to establish SORD as a causative gene for dHMN.
山梨醇脱氢酶基因(SORD)已被确定为遗传性神经病隐性形式的一个新致病基因,包括2型夏科-马里-图斯病和远端遗传性运动神经病(dHMN)。我们的研究结果揭示了四个中国dHMN家系中SORD基因内的两个新变异(c.404 A > G和c.908 + 1 G > C)以及一个已知变异(c.757delG)。体外cDNA聚合酶链反应证实,c.908 + 1 G > C变异与SORD转录本的剪接受损有关。体外细胞功能研究表明,c.404 A > G变异导致SORD聚集形成且蛋白质溶解度低,证实了SORD变异的致病性。我们提供了更多证据来确定SORD是dHMN的致病基因。